Running Point Capital Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Running Point Capital Advisors, LLC

  • $256 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
SELL
$11.23 - $19.59 $123 - $215
-11 Reduced 0.11%
10,000 $138,000
Q1 2022

May 12, 2022
BUY
$13.37 - $17.79 $133,847 - $178,095
10,011 New
10,011 $163,000

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Running Point Capital Advisors, LLC Portfolio

Follow Running Point Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Running Point Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Running Point Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email